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Available online 9 August 2013Abstract Basal forebrain cholinergic neurons (bfCNs) which provide innervation to the hippocampus and cortex, are required
for memory and learning, and are primarily affected in Alzheimer's Disease (AD), resulting in related cognitive decline. Therefore
generation of a source of bfCNs from human pluripotent stem cells (hPSCs) is crucial for in vitro disease modeling and development
of novel AD therapies. In addition, for the advancement of regenerative approaches there is a requirement for an
accurate developmental model to study the neurogenesis and survival of this population. Here we demonstrate the efficient
production of bfCNs, using a novel embryoid body (EB) based non-adherent differentiation (NAdD) protocol. We establish a
specific basal forebrain neural stem cell (NSC) phenotype via expression of the basal forebrain transcription factors NKX2.1 and LHX8,
as well as the general forebrain marker FOXG1. We present evidence that this lineage is achieved via recapitulation of embryonic
events, with induction of intrinsic hedgehog signaling, through the use of a 3D non-adherent differentiation system. This is the
first example of hPSC-derived basal forebrain-like NSCs, which are scalable via self-renewal in prolonged culture. Furthermore upon
terminal differentiation these basal forebrain-like NSCs generate high numbers of cholinergic neurons expressing the specific
markers ChAT, VACht and ISL1. These hPSC-derived bfCNs possess characteristics that are crucial in a model to study AD related
cholinergic neuronal loss in the basal forebrain. Examples are expression of the therapeutic target p75NTR, the release
of acetylcholine, and demonstration of a mature, and functional electrophysiological profile. In conclusion, this work provides
a renewable source of human functional bfCNs applicable for studying AD specifically in the cholinergic system, and also provides a
model of the key embryonic events in human bfCN development.
© 2013 Elsevier B.V. All rights reserved.⁎ Corresponding author. Fax: +44 117 331 3169.
E-mail address: Maeve.Caldwell@Bristol.ac.uk (M.A. Caldwell).
1873-5061/$ - see front matter © 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.scr.2013.08.002
1207NadD of human pluripotent stem cells generates basal forebrain cholinergic neuronsIntroduction
AD is the most common age-related neurodegenerative
disease estimated to affect approximately 30 million people
worldwide (Holtzman et al., 2011). Most prevalent symp-
toms are confusion and memory loss caused by synaptic
dysfunction and neuronal death. One of the primary
neuronal populations affected are the bfCNs, which are
partly responsible for these cognitive deficits (Holtzman et
al., 2011; Everitt and Robbins, 1997).
The progress of AD research has been inhibited by lack of
accurate models that recapitulate the complex facets of AD
(Han et al., 2011). Recent advances in hPSC technology have
made it possible to produce regionally specified neuronal
populations affected by various neurodegenerative condi-
tions, providing a novel source of human neurons for in vitro
disease modeling (Nat and Dechant, 2011; Liu, 2011). It is
essential that these neurons are phenotypically accurate and
functional, and that they can also be used to model the
embryonic differentiation of these populations, which is
applicable to their regenerative potential (Liu, 2011).
Previous studies have demonstrated the generation of
cholinergic neurons, with a potential basal forebrain pheno-
type (Nilbratt et al., 2010; Bissonnette et al., 2011). However,
high levels of specific extrinsic factors were used to direct
differentiation, of which their exact role remains unclear. Our
aim was to provide a method of generating high numbers of
bfCNs in keeping with a requirement for a developmental
model; a reductionist approach, where the cells establish their
own developmental cues, in parallel to the developing embryo.
Our reasoning for the advantages of this are two-fold; firstly we
believe this approach provides a superior and more accurate
developmental model to study the innate acquisition of basal
forebrain cholinergic fate; furthermore by using intrinsic cues
from development we would suggest that the resulting
neuronal progeny would be more similar to those in the
developing brain. We present evidence that a method of
EB-based non-adherent differentiation (NAdD) is sufficient for
the induction of basal forebrain fate. In the embryo, bfCNs
differentiate in the ventral telencephalon, which will go on to
form part of the basal forebrain (Marin et al., 2000). Hedgehog
signaling is the master controller of dorso-ventral patterning,
inducing ventral fate along the entire length of the developing
neural tube (Briscoe and Ericson, 1999). We show that NAdD
results in the production of the secreted hedgehog ligand SHH,
which as in the embryonic ventral telencephalon, results in
expression of the specific transcription factors NKX2.1 and
LHX8 (Marin et al., 2000; Ericson et al., 1995a; Shimamura et
al., 1995; Pera and Kessel, 1997; Gunhaga et al., 2000; Sussel
et al., 1999; Flandin et al., 2010; Zhao et al., 2003; Fragkouli et
al., 2005). Optimization of the NAdD protocol generated an
expandable population of NKX2.1+/LHX8+ NSCs, which retained
this phenotype through long-term expansion. Upon terminal
differentiation the NSCs generated TUJ1+/ChAT+ cholinergic
neurons, demonstrating characteristics of bfCNs present in the
adult human brain. Briefly they expressed high levels of p75NTR
protein, aswell as cholinergic receptor subunit genes, essential
for their function and upon transplantation the NSCs were also
able to differentiate into cholinergic neurons in the adult rat
brain. Furthermore, the hPSC-derived bfCNs were electrically
active, released acetylcholine, and generated neuronal action
potential firing as well as spontaneous activity. Therefore ourwork provides a model of the human bfCN population, which
meets the criteria required for a multipurpose model of the
basal forebrain cholinergic system, both developmentally and
also in a mature functional context.
Materials and methods
hPSC culture
Shef hES lines were originally acquired from the UK-Stem Cell
Bank. The NAS2 hiPS cell line was generated as previously
described (Devine et al., 2011). The MSU0001 hiPS cells were a
kind gift from Dr Jose Bernado Cibelli, Cellular Reprogramming
Laboratory, Michigan State University (Ross et al., 2010). Cells
weremaintained uponmitotically inactivatedmouse embryonic
fibroblasts in growth media (80% KO-DMEM, 20% Knock-out
Serum Replacer (KSR), 1% non-essential amino acids, 2 mM
Glutamax, 0.1 mM ß-Mercaptoethanol, and 1% penicillin and
streptomycin all Life Technologies), supplemented with either
10 ng/ml (Shef hES and NAS2 hiPS) or 20 ng/ml (MSU0001) FGF2
(Peprotech). Cells were passaged manually.
Neural differentiation optimized for generation of
basal forebrain progenitors
A minimum of six 5 cm plates, containing approximately 25
colonies each were required to provide an adequate number of
cells. Cells were washed with KO-DMEM (Life Technologies)
and incubated in 1 mg/ml Collagenase IV (Life Technologies)
for 30 min at 37 °C. Whole-colonies were remove and cen-
trifuged at 50 ×g for 5 min. Colonies were chopped into
uniform 150 μm pieces using a McIlwain tissue chopper (Mickle
Engineering, Gomshall, U.K.), and resuspended in growth
media (described above), without FGF2 but supplemented
with 10 μM of the ROCK inhibitor Y27632 (Tocris). The pieces
were transferred to a 25 cm (Everitt and Robbins, 1997) flask,
coated with poly(2-hydroxyethyl methacrylate) (Sigma) to
prevent cell attachment. Colony pieces formed spheres
and differentiated into EBs over 4 subsequent days, after
which they were transferred into modified chemically defined
media (CDM) (Joannides et al., 2007), (BSA was substituted
with 400 μg/ml Albumax-II, Life Technologies). CDM was
supplemented with 10 μM Y27632 (Tocris) and 20 μM of the
Nodal/TGF-β signaling inhibitor SB431542 (Tocris). During
this period of neural enrichment EBs were regularly triturated
with P1000 tip to prevent aggregation. After 8 days the
neurospheres were transferred into NEM (7 parts KO-DMEM to
3 parts F12, 2 mM Glutamax, 1% penicillin and streptomycin,
supplemented with 2% B27 (all Life Technologies), plus
FGF2 and EGF [20 ng/ml] and heparin [5 μg/ml]) (Svendsen
et al., 1998). NEM also contained 20 μM SB431542 and 10 μM
Y27632, for the initial 10 day expansion period. We found that
regular trituration of the EBs throughout enrichment, and
passaging using the McIlwain tissue chopper (Mickle Engineer-
ing, Gomshall, U.K.) at day 10 of expansion were crucial to
achieve a pure population of NSCs. Neurospheres were
passaged every 2 weeks by chopping them into 200 μm pieces
(Svendsen et al., 1998) (Anderson et al., 2007).
For monolayer differentiation hPSCs were seeded on
Matrigel coated plastic-ware and differentiated as described
(Chambers et al., 2009).
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Neurospheres were dissociated using Accutase (Sigma) and
resuspended in NEM without mitogens. 50,000 NSCs were
plated on each PDL/laminin coated coverslip. For NESTIN/
MSI1 counts cells were left for 12 h prior to fixation. Other
plating times are detailed in the Results section.Whole neurosphere terminal differentiation for
iummunocytochemistry
Whole neurospheres were plated on PDL/laminin coated
coverslips in NEM and allowed to differentiate for 28 days
(Caldwell et al., 2001).Semi-quantitative RT-PCR
Total RNA was extracted (RNeasy mini system with Qiazol,
Qiagen), treated with RNase-free DNase I (Roche) and
re-purified using the RNeasy Minelute system (Qiagen). 0.25–
1 μg of RNA was reverse-transcribed using Superscript-III (Life
Technologies) according to the manufacturer's instructions.
PCR was carried out using GoTaq (Promega). Sequences of
individual primer pairs and PCR conditions are detailed in
Supplementary Table S1. PCR products were visualized by
agarose/ethidium bromide gel electrophoresis.Immunocytochemistry
Cells were fixed for 20 min at room temperature in 4%
paraformaldehyde (Fisher), with the exception of MSI1
staining where cells were fixed with ice cold 100% methanol
for 20 min at −20 °C. Cells were blocked at room temper-
ature in PBS/10% goat/2% BSA/Triton X-100 (0.1% for single
cells or 0.3% for spheres). Primary antibodies were incubat-
ed overnight at 4 °C in PBS/2% goat serum/0.2% BSA/Triton
X-100. Primary antibodies: OCT4 (SCBT, 1:50), SSEA-4
(DSHB, 1:4), NESTIN (Abcam, 1:300), MSI1 (Abcam, 1:200),
SOX11 (Millipore, 1:5000), Ki67 (Vectorlabs, 1:300), TUJ1
(Abcam and Millipore, both 1:500), GFAP (Dako, 1:1000),
GABA (Sigma, 1:500), TH (Millipore, 1:250), MAP2ab (Sigma,
1:250), ChAT (AB143, Millipore, 1:400), NKX2.1 (Abcam
1:100), Isl1 (Abcam, 1:500), and VAChT, (SySy 1:1000).
Secondary antibodies were incubated at room temperature
for 2 h in PBS/1% goat serum/Triton X-100. Cells were
co-stained with Hoechst 33258 (Sigma) and mounted in
Vectorshield (Vectorlabs). Staining was visualized using an
upright fluorescent microscope. For TUJ1/GFAP and ChAT/
TUJ1 cell counts a Leica SP5 confocal imaging system was
used and image analysis carried out using Leica LAS confocal
software. All images were processed using ImageJ and Adobe
Photoshop CS3.Taqman gene expression analysis of LHX8
Total RNA was extracted and processed as described. cDNA
was generated using Taqman reverse transcription reagents,
and the qPCR assay was carried out using the Taqman
Universal Master Mix and Taqman assays for LHX8 and GAPDHas the endogenous control (all Life Technologies). Each 20 μl
reaction contained 100 ng cDNA.SHH ELISA
Media was and stored at −80 °C. SHH in the media was
assayed using a human specific ELISA kit (Abcam) according
to the manufacturer's instructions. For comparison between
differentiation protocols SHH was normalized against total
protein in cell lysate.Immunoblot
Cells were lysed in RIPA (50 mM Tris HCl pH 8, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) plus
protease inhibitor (Roche). Protein was quantified using a
BCA assay (Thermo Scientific) and 20 μg was resolved on a
12% polyacrylamide SDS-Tris-Glycine gel. Proteins were
transferred onto a 0.45 μm PVDF membrane (Roche) which
was blocked with 10% non-fat milk in TBS buffer with 0.1%
Tween-20 (Sigma). Incubation with primary antibody (rabbit
anti-p75 (Sigma) 1:1000; rabbit anti-NKX2.1 (Abcam) 1:1000,
rabbit anti-Lhx8 (Genetex) 1:1000, rabbit anti-syn1 (SySy)
1:1000, and mouse anti-α-Tubulin (Sigma) 1:10,000) was
carried out overnight at 4 °C in blocking buffer. Membranes
were incubated with the appropriate HRP-labeled secondary
antibody for 2 h at room temperature. Protein bands were
visualized using Pierce Plus Substrate (Thermo).Acetylcholine release assay
Acetylcholine release was assessed in 28-day terminally
differentiated hPSC-derived neurospheres as described
(Zoukhri and Kublin, 2002). We collected samples to assess
both spontaneous and (Carbachol CCh; 50 μM) induced
release using an Amplex Red Acetylcholine assay kit (Life
Technologies).Calcium imaging
Calcium imaging was carried out on 28-day terminally
differentiated hPSC-derived neurospheres. Cells were washed
with HBS buffer (mM: NaCl, 140; KCl, 3; Hepes, 10;
glucose, 10; CaCl2, 2; MgCl2, 2; TTX, 500 nM; glycine,
1 mM; picrotoxin, 100 mM; pH 7.4; and osmolarity 300–
310 mosmol l−1) and loaded with 5 mM of the membrane-
permeant Ca2+ indicator fluo-3 AM made up in 1 mg × ml−1
BSA/HBS at 37 °C for 25 min. Cells were washed and
incubated for 20 min in natural atmosphere at 22 °C to allow
de-esterification of the fluorophore. Cells were exposed to
CCh (50 μM) and KCl (100 mM). Cells were viewed on a Leica
DM IRBE fluorescence microscope, using a green filter set and
perfused continuously with HBS buffer at ~2 ml × min−1. One
image was obtained every 5 s. Fluorescence of individual cells
in each preparation was determined using Image J image
analysis program (available at http://rsb.info.nih.gov/ij/)
and expressed relative to baseline. The mean peak fluores-
cence was calculated.
Figure 1 EB-based non-adherent differentiation (NAdD) demonstrated efficient induction of basal forebrain markers. (A) Schematic of
the EB-based NAdD protocol, of which media components were also tested in a monolayer format, versus the monolayer dual SMAD
inhibition protocol (Chambers et al., 2009). (B) Protein samples were collected on days 2, -4 and -8 of the three protocols, whichwewould
consider the early inductive stage of the neural differentiation process. Immunoblot showed that expression of the basal forebrainmarker
NKX2.1 was highest in the NAdD system at all time points examined, compared to monolayer differentiation of hPSCs either in the same
media components as were used in NAdD), or via dual SMAD inhibition which is an established monolayer method of hPSC differentiation
(Chambers et al., 2009) (days 2 and 4 n = 2, day 8 n = 5 SEM, two tailed t-test). By day 8, Lhx8 expression was higher in the NAdD
protocol compared to the other two protocols. (C) The mature hedgehog ligand, SHH was present at significantly higher levels in the
NAdD protocol after 4 days of differentiation, compared to monolayer differentiation of in either the same media components as
were used in NAdD (n = 2, SEM, two tailed t-test; ** p = b0.05), or via dual SMAD inhibition (Chambers et al., 2009) (n = 2, SEM, two
tailed t-test; * p = b0.05). For comparison between differentiation protocols SHH was normalized against total protein in cell
lysate.
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For electrophysiology, after 28 days NEM media was
replaced with modified neuronal differentiation media
(NDM) (Johnson et al., 2007) containing 1 μg/ml lamininand 0.1% horse serum (Life Technologies) and cells were
allowed to differentiate for a subsequent 5–6 weeks. For
whole-cell recordings, coverslips were transferred to the
recording chamber, and submerged in aCSF, (mM: 124 NaCl,
3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgSO4 and 10
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(4–6 MΩ) solutions comprised (mM): 140 K-gluconate, 10
HEPES, 10 BAPTA, and 4 Mg 2+-ATP, pH 7.2, 290 mOsm. For
recording spontaneous activity, the pipette solution contained
(mM): 20 KCl, 121 K-gluconate, 10 HEPES, 10 BAPTA, and
4 Mg 2+-ATP, pH 7.2, 290 mOsm. Cells were voltage-clamped at
a resting membrane potential between −60 mV and −70 mV.
During current-clamp recordings, 40 pA current injection was
maintained. Clamp recordings were carried out using an
Axopatch 700B amplifier (Axon Instruments). Current signals
were captured on-line by a 486 computer at a sampling
frequency of 2 kHz, and digitized at 10 kHz with the voltage
signal via a 1200 Digidata interface digitizer (Axon Instru-
ments). Only cells with series resistance of b25 MΩ with a
change in series resistance of b10% from the start were
included in this study. The frequency of spontaneous activity
was measured for each experiment and normalized as mean
values ± sem. Background noise threshold was set at 10 pA to
determine spontaneous responses, therefore spikes larger
than 20 pA were included in frequency calculations. Acquired
data was analyzed using OriginPro 7.5. All experiments were
performed at 27–29 °C. TTX (500 nM, Sigma) was used where
indicated.
Transplants
10-week old, female Lewis rats (Harlan, UK) received a
unilateral graft to the medial septum (MS; n = 6. AP, +0.7;
ML, +0.2; DV, −7.0) (Wu et al., 2002). 3 days prior to surgery
hPSC-derived neurospheres were chopped at 200 μm and
media was supplemented with laminin (1 μg/ml). 10-small
neurospheres, (~35,000 cells) were loaded in 5 μl NEM into a
5 μl zero-dead volume, plunger-in-the-needle SGE glass
micro-syringe incorporating a 30-gauge stainless steel blunt
cannula (Fisher Scientific, UK). Rats were immunosuppressed
with a daily subcutaneous injection of Cyclosporin A (10 mg/kg,
Sandimmune, Sandoz), which began 48 h prior to surgery and
continued thereafter. Grafts were analyzed 8–9 weeks post
surgery.
Immunohistochemistry
Animals were terminally anesthetized and transcardially
perfused with 4% paraformaldehyde. Brains were post-fixed
overnight and dehydrated in 30% sucrose in 0.1 M phosphateFigure 2 The optimized NAdD protocol could efficiently and reproduc
of the differentiation protocol used for neural induction of the hES line
(B) RT-PCR demonstrated that differentiating hPSCs showed rapid down
of mesendoderm markers (T, GATA4, AFP) and neuroectoderm marke
exclusive neural marker expression (SOX1, N-CAM), indicating a pure
Immunocytochemistry on acutely plated 30-day expanded single NSCs
from the hiPS (C) and hES lines (D) as confirmed by quantification of
(F) Quantitative PCR demonstrated expression profiles of genes involve
protocol. For ventral specific markers we saw relatively consistent ex
saw a significant increase in the general forebrain transcription fact
expansion stage of the protocol (n = 4). (G, H) The basal forebrain phe
NESTIN+ NSCs within the expanding NAS2 hiPS-derived neurosphere
(H). Scale bars: (C, D) 50 μm; (G) 100 μm; (H) 25 μm.buffer. 40 μm free-floating sections (1 in 6 series) were
blocked for 2 h in PBS/20% goat serum/2% BSA/0.1% Triton
X-100. Primary antibodies were incubated overnight at 4 °C
in PBS/2% goat serum/0.2% BSA/0.1% Triton X-100, followed
by a 2 h incubation in secondary antibodies made up in 2%
PBS/2% goat serum/0.2% BSA/0.1% Triton X-100. Primary
antibodies used were mouse anti-HNA (1:400, Millipore),
rabbit anti ChAT (1:400, Millipore) and rabbit anti-Double
Cortin (DCX; Abcam; 1:500).Results
Induction of ventral forebrain markers in hPSCs
by embryoid body versus adherent differentiation
methods
The most evident way to manipulate hPSC differentiation in
the absence of extrinsic factors was to manipulate the
physical environment to which the differentiating hPSCs
were exposed. Therefore we compared three methods for
the neural induction; EB-based NAdD versus differentiation
as a monolayer, with the comparison essentially being
between a 3D environment, more similar to that in the
early embryo, versus an adherent, 2D environment respec-
tively. EB formation recapitulates the early embryonic
environment to provide cues for acquisition of cell fate.
This results in differentiation of the three embryonic germ
layers mesoderm, endoderm and ectoderm, the latter giving
rise to the neuroectoderm and thus NSCs (Fig. 1A) (Martin
and Evans, 1975).
We generated EBs from aggregates of hPSCs in Knock-out
Serum Replacer (KSR) based media, in the presence of ROCK
inhibitor, Y-27632, both ofwhich promote cell survival (Fig. 1A)
(Watanabe et al., 2005) (Watanabe et al., 2007). After 4 days
EBs were transferred into a chemically defined media (CDM),
containing the Nodal/TGF-β inhibitor, SB431452, to promote
differentiation and expansion exclusively of neural cells, rather
than mesendodermal fates (Fig. 1A) (Joannides et al., 2007;
Chambers et al., 2009; Vallier et al., 2004). In parallel hPSCs
were differentiated as a monolayer in the same media com-
ponents as the NAdD protocol. We also employed a third
technique, a widely used monolayer based method, developed
by Chambers et al. (2009), termed dual SMAD inhibition
(Fig. 1A). This protocol differentiates hPSCs as a monolayer inibly generate NSCs with a basal forebrain phenotype. (A) Schematic
s, Shef2, Shef3 and Shef6, and the hiPS lines NAS2 and MSUH0001.
-regulation of pluripotencymarkers (OCT4,NANOG), unregulation
rs (SOX1, N-CAM). Neural enrichment and expansion resulted in
population of NSCs. GAPDH was the endogenous control. (C–E)
demonstrated equivalently high numbers of NESTIN+/MSI1+ cells
cell numbers (E N97%, n = 3, n = 2 respectively, SEM, P N 0.05).
d in ventral forebrain development over the duration of the NAdD
pression, showing no statistically significant changes, however we
or FOXG1 which increased when hPSC-derived NSCs were in the
notype was confirmed by immunocytochemistry showing NKX2.1+/
(G), and also upon acute plate-down of Shef6 hES derivatives
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downstream of BMP signaling, which promotes neural differ-
entiation (Fig. 1A). At days 2, 4 and 8, samples were taken from
the three protocols and screened by immunoblot for the basal
forebrain transcription factors NKX2.1 and LHX8 (Nat and
Dechant, 2011; Liu, 2011) (Fig. 1B). At all time points examined
NKX2.1 was expressed at higher levels in cells undergoing
neural differentiation in the NAdD protocol, compared to
either of the monolayer differentiation protocols (Fig. 1B).
LHX8 was expressed at similar levels at the start of
differentiation across the protocols, but by day 8 expres-
sion of LHX8 was higher in the NAdD protocol versus either
of the monolayer protocols (Fig. 1B). From this experiment
we concluded that the EB-based NAdD protocol generates a
basal forebrain identity during neural differentiation with
greater efficiency than neural differentiation of hPSCs as a
monolayer.
In the developing embryo acquisition of basal forebrain
identity is regulated by hedgehog signaling, with secretion of
the SHH ligand from tissues adjacent to the ventral neural
tube, and then the ventral neural tube itself (Ericson et al.,
1995a; Echelard et al., 1993; Ericson et al., 1995b; Shimamura
and Rubenstein, 1997). Therefore we hypothesized that the
high levels of NKX2.1 and LHX8 expression seen in the NAdD
protocol must be due to higher levels of secretion of the
mature form of the hedgehog ligand, SHH, compared to the
two monolayer protocols. An ELISA on media collected from
day 4 of each protocol confirmed 2–3 fold higher amounts of
SHH secretion in the NAdD protocol compared to the
monolayer protocols (Fig. 1C). Together this data clearly
demonstrated that regardless of basic media composition, the
physical environment in which the cells differentiated
ultimately determined their acquisition of a basal forebrain
fate, and this was due to the positive influence of the
non-adherent 3D differentiation environment on hedgehog
signaling.Efficient NAdD of hES and hiPS cells into an
expanding population of NSCs
We went on to optimize the NAdD protocol with the aim to
produce a pure population of basal forebrain-like NSCs. We
extended the period of neural enrichment in CDM, after which
cell aggregates were transferred into Neural Expansion Media
(NEM) containing the growth supplement B27 plus FGF2, EGF
and heparin and expanded as non-adherent neurospheres,
similar to their human fetal counterparts (Anderson et al.,
2007; Svendsen et al., 1998; Carpenter et al., 1999; Vescovi et
al., 1999). The optimized protocol therefore consisted of
three specific stages; 1) EB formation, 2) neural enrichment,
and 3) expansion as non-adherent neurospheres (Fig. 2A,
Supplementary Fig. S1A). RT-PCR demonstrated rapid down-
regulation of pluripotency markers and expression of various
germ layer markers (Fig. 2B). We found extending the
enrichment period to 8 days, in addition to maintenance of
SB431452 throughout enrichment and the first 10 days of
expansion was required to achieve a pure population of
expanding NSCs, as indicated by RT-PCR at day 30 of expansion
(Fig. 2B).
This was confirmed by the high percentages of single plated
cells that co-expressed the NSC markers NESTIN and MSI1(Figs. 2C, D). We saw no difference in the efficiency of neural
conversion of hES compared to hiPS lines, of which over 97%
were positive for each marker (Fig. 2E). Furthermore similar
results were achieved with every hPSC line differentiated via
NAdD (Figs. 2C–E, Supplementary Figs. S1B–E).
To evaluate at what stage of the NAdD protocol the ventral
telencephalic identity was induced we profiled the expression
of a number of genes involved in early regionalization of the
telencephalon. These were the ventral telencephalic markers,
SHH, NKX2.1 and LHX8, in addition to the general forebrain
transcription factor FOXG1 (Fig. 2F). Expression of the ventral
marker genes SHH,NKX2.1 and LHX8was present from EB stage
of the protocol (day 4) and there were no significant changes in
their expression levels for the duration of the NAdD protocol
(Fig. 2F). This confirmed that ventral identity of the cells was
induced from the earliest EB stage of the protocol. This would
agree with the expression of SHH in the media at this stage,
as shown in Fig. 1C. We did however see a 3-fold increase
in the expression of FOXG1 10 days into the expansion
stage of the protocol (Fig. 2F). This could be due to the
presence of FGF2 in the expansion media. FGF signaling
directly induces FOXG1 expression in the developing
telencephalon, and this specifically involves the FGFRs to
which FGF2 is known to bind (Shimamura and Rubenstein,
1997).
We confirmed continual expression of the NKX2.1 protein
by immunoblot (Supplementary Fig. S1F), and immunocyto-
chemistry demonstrated NKX2.1 expression in the expanding
hPSC-derived neurospheres and also acutely plated NSCs
(Figs. 2G, H). We quantified the proportion of NKX2.1
expressing cells within the population and found that for
the NAS2 hiPS-derived NSCs, 92.87 ± 3.22% of the NESTIN
expressing also expressed NKX2.1 (n = 2, SEM). This con-
firmed that the NAdD protocol efficiently and reproducibly
induces a basal forebrain phenotype.
We next assessed NSC marker expression after 90 days
expansion, considered a ‘long-term’ culture period. DACH1
and PLAGL1, which are considered markers of the earliest
definable NSC were expressed and maintained (Fig. 3A)
(Elkabetz et al., 2008). NESTIN and MSI1 were present in the
same high proportion of cells (Fig. 3B). Expression of the
definitive NSC marker SOX1 was also maintenance in 90-day
expanded hiPS and hES-NSC populations (Figs. 3C, D).
Importantly we saw maintained expression of NKX2.1 after
90 days expansion (Figs. 3E, F). Together these findings
suggested the ‘stemness’ of the NSCs and their basal forebrain
identity was maintained, even with long-term expansion in
culture.Confirmation that hedgehog signaling the EB is
responsible for ventralization of the hPSC-derived
NSCs
It is well established that in the developing basal forebrain
hedgehog signaling is responsible for early induction of ventral
identity in neural progenitors, resulting in the expression of
NKX2.1 and LHX8 (Nat and Dechant, 2011; Liu, 2011). Further
analysis of secreted SHH levels in the EB media showed a
significant decrease between day 2 and day 4 suggesting that
secretion of SHH was highest in the earliest stages of germ
layer differentiation (Fig. 4A). This was therefore prior to the
Figure 3 The basal forebrain progenitor phenotype of the hPSC-derived NSCs was maintained throughout expansion in culture.
(A) Semi-quantitative RT-PCR revealed that the hPSC-derived NSCs demonstrated expression of early neural ‘rosette’ markers DACH1
and PLAGL1 after 30 days in expansion (D30), and this was maintained at the later time-point, after 90 days. (B) Similarly,
immunocytochemistry and subsequent quantification of the Shef3 hES-derived NSCs revealed maintenance of the stem cell markers
NESTIN and MSI1 from 30 to 90 days in culture. This suggested that by generating hPSC-derived NSCs via NAdD produced an NSC
population, which retained the same phenotype even after multiple proliferations and passages (N98% n = 3, SEM). (C, D) Further
confirmation came from immunocytochemistry demonstrating continued expression of the definitive NSC marker, SOX1, shown here
alongside NESTIN, after a 90 day expansion period of both the NAS2 hiPS and Shef3 hES-derived NSCs. This also established that
maintenance of a neural progenitor phenotype was universal, regardless of the hPSC line. (E, F) Critically hPSC-derived NSCs also
maintained their basal forebrain characteristics throughout expansion, as demonstrated by their continued expression of NKX2.1 at
90 days in culture, shown here alongside NESTIN. Scale bars: (C, D, E) 50 μm; (F) 25 μm.
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FGF2 and EGF and in the absence of any factors known to
influence dorso-ventral patterning, or hedgehog signaling.
This therefore confirmed that it was the environment of the
EB that led to the initiation of hedgehog signaling via secretion
of SHH.
For further validation that SHH was responsible for the
observed basal forebrain phenotype we exposed EBs to
cyclopamine, a potent inhibitor of downstream hedgehog-
signal transduction. We used NKX2.1 protein levels as a
read-out for active hedgehog signaling, as NKX2.1 expression
is positively regulated by SHH (Ericson et al., 1995a; Pera
and Kessel, 1997). EBs were exposed to cyclopamine (50 μM)
for the first 4 days of the neural enrichment in CDM and we
saw a robust reduction in levels of NKX2.1 (Fig. 4B).We went on to further establish the extent to which this
protocol recapitulated the development of bfCNs in vivo.
Accurate reproduction of embryonic fate acquisition would
be critical should these cells be used as a model to study
bfCN neurogenesis in vitro. NKX2.1+/NESTIN+ NSCs present
12 h after mitogen withdrawal (Fig. 4C) start to terminally
differentiate into NKX2.1+/TUJ1+ neuronal progenitors
by 24 h (Figs. 4D, E). Finally the mature hPSC-derived
bfCNs also expressed ISL1, a transcription factor, present in
mature cholinergic neurons (Fig. 4F) (Elshatory and Gan,
2008). These findings confirmed intrinsic hedgehog signal-
ing in the EB formation stage, thus that NAdD induces a
ventral telencephalic phenotype, which mimics that of
differentiating bfCNs within the MGE of the embryonic
telencephalon.
Figure 4 Hedgehog signaling is responsible for the ventralization of the hPSC-derived NSCs, which recapitulate in vivo
differentiation of bfCNs in the basal forebrain upon mitogen withdrawal. (A) Secreted SHH was detected in day 2 and day 4 EB media
(n = 2, SEM, two tailed t-test * p = b0.05). (B) Addition of the hedgehog antagonist cyclopamine for 4days as EBs entered neural
enrichment resulted in a significant reduction in NKX2.1 protein levels (n = 3, SEM, two tailed t-test *P = b0.05). This therefore
confirms that intrinsic hedgehog signaling in the NAdD system is responsible and sufficient to ventralize the cells, resulting in evident
basal forebrain characteristics. (C–E) NKX2.1 was co-expressed with NESTIN by the hPSC-derived NSCs 12h after mitogen withdrawal
(C), and maintained in TUJ1+ neuronal progenitors 24 h after mitogen withdrawal (D,E). (F) Terminally differentiated hPSC-derived
TUJ1+ neurons also co-expressed basal forebrain, cholinergic transcription factor, ISL1. This hedgehog regulated temporal expression
of NKX2.1, followed by expression of ISL1 marks the transition from basal forebrain progenitor to bfCN, as occurs in the developing
embryonic brain. Scale bars: (C, D) 25 μm; (D, E) 50 μm.
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After terminal differentiation, immunocytochemistry analy-
sis of the hPSC derivatives revealed the presence of both
class III β-Tubulin (TUJ1)+ neurons and GFAP+ glial cells
(Figs. 5A–D). Quantification using confocal microscopy
throughout and surrounding the terminally differentiated
neurospheres revealed a high percentage of neurons (87.82%
±2.04, SEM, n = 3, Fig. 5E).
We went on to further characterize the subtype of the
neurons generated in this study. Widespread expression of
the ventral cholinergic transcription factor ISL1, as shown inFig. 4F, was evidence that a cholinergic neuronal subtype was
generated from the hPSC-derived NKX2.1+ NSCs. Further
immunocytochemistry analysis confirmed that the majority of
neurons in the population were cholinergic, co-expressing TUJ1
with Choline AcetylTransferase (ChAT) (Fig. 5F). Quantification
using confocal microscopy throughout and surrounding the
terminally differentiated neurospheres revealed 90.9 ± 1.54%
of the Shef3 hES-derived neurons (SEM, n = 3) and 92.39 ±
2.31% of the NAS2 hiPS-derived neurons (SEM, n = 2) were in
fact cholinergic (Fig. 5G). TUJ1+/ChAT+ neurons were present
throughout the center of the terminally differentiated neuro-
spheres, where ChAT was distributed in the cytoplasm
(Fig. 5H). We also saw TUJ1+/ChAT+ neurons in the area
Figure 5 hPSC-derived NSCs demonstrate a propensity towards cholinergic neuronal differentiation. (A) 28-day terminally
differentiated Shef3 hES-derived neurospheres predominantly consisted of TUJ1+ neurons, intermixed with GFAP+ glial progeny. (B–D)
This high neurogenic capacity was consistently demonstrated by each hPSC line differentiated using the NAdD system, as shown by the
high numbers of TUJ1+ neurons. (E) Quantification of Shef3 hES derivatives by confocal microscopy confirmed this propensity towards
neuronal differentiation, with hES-derived NSCs generating 87.82% neurons upon terminal differentiation (n = 3, SEM). After a 90-day
expansion period of expansion in culture, the hES-derived NSCs maintained this neurogenic capacity, with 83.06% being TUJ1+ neurons
(n = 2, SEM). (F) Further characterization revealed that the majority of neurons were cholinergic, Co-expressing TUJ1, and the
cholinergic marker ChAT. (G) Quantification revealed 90.9% of the Shef6 hES-derived neurons and 92.39% of the NAS2 hiPS-derived
neurons were ChAT+ (n = 3, n = 2 respectively, SEM), confirming that the NAdD system of differentiation produced a basal forebrain,
cholinergic phenotype, regardless of the identity of the parent cell line. (H, I) Detailed confocal microscopywas used for quantification of
cell numbers, revealing ChAT+/TUJ1+ neurons throughout the center (H) and also around the edge of the neurosphere (I). (J) The
terminally differentiated neurons were also VAChT+, another marker of cholinergic neurons shown here with the neuronal marker
MAP2ab. Scale bars: (A, B, F) 250 μm; (H) 25 μm; (C, D, I and J) 50 μm.
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1216 L.A. Crompton et al.surrounding the neurosphere (Fig. 5I). Further verification
of the cholinergic phenotype was provided by expression of
the Vesicular Acetylcholine Transporter (VAChT), the protein
responsible for loading acetylcholine into synaptic vesicles,
another specific marker of cholinergic neurons (Fig. 5J). Within
the differentiated neurospheres we also saw small numbers of
GABAergic neurons and Tyrosine Hydroxylase (TH) expressingFigure 6 The hPSC-derived bfCNs possessed a phenotype characte
expressed of p75NTR at high levels, comparable to that of PC12 cells (
cholinergic receptor subunit genes nAChR4, nAChRb2 and mAChR3,
used as an endogenous control for the presence of cholinergic neur
adult rats. As shown in this schematic of the rat forebrain HNA+ hu
overlying CX (red dots), and also in MS (green dots). (D) As shown her
immature neuronal marker, DCX, when present in the CX. Interesting
The white arrowhead indicates the endogenous DCX+ progenitors w
Within the MS the grafted HNA+ cells spanned the majority of the dors
more ventral region, as indicated by the dashed line on (E). High ma
co-expressing ChAT within the MS (F–K). The cells within the graft
arrow heads). HNA, human nuclear antigen; CX, cortex; MS, medial se
DCX, doublecortin. Scale bars: (F–L) 40 μm.dopaminergic neurons, which are two neuronal subtypes also
found in the forebrain (Supplementary Figs. S2 A and B).
Together this data demonstrated that the NAdD system of
differentiation of hPSCs, via an expandable basal forebrain-
like NSC, was able to reproducibly and preferentially generate
high numbers of neurons, of which the majority, over 90% on
average, were cholinergic.ristic of those in the adult brain. (A) NAS2 hiPS-derived neurons
Masoudi et al., 2009). (B) RT-PCR demonstrated expression of the
in addition to the glutamate receptor gene NMDAR1. ChAT was
ons. (C) hES and hiPS-derived NSCs were grafted into the MS of
man grafted cells were found in two specific areas, within the
e in a Shef6 hES-derived NSC graft, HNA+ cells only expressed the
ly HNA+/DCX+ cells were never present within the underlying MS.
ithin the ventricular zone of the rat's lateral ventricle. (E–K)
o-ventral range of the MS, but ChAT+ cells were only found in the
gnification confocal z-stacks were used to image the HNA+ cells
were closely associated with ChAT positive projections (filled
ptum; CC, corpus collosum; LV, lateral ventricle; STR, striatum;
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human adult bfCN
We further characterized the neurons to establish their
suitability as a model of bfCNs in the mature human brain.
In the adult brain the neurotrophin receptor p75NTR is
expressed by over 90% of bfCNs and is a key mediator in
cholinergic signaling and hippocampal innervations from the
basal forebrain (Allen and Dawbarn, 2006; Coulson et al.,
2009). Crucially immunoblot analysis established high levels
of the p75NTR protein in hiPS-NAS2-derived neurons (Fig. 6A).
Furthermore, RT-PCR demonstrated expression of various
important receptor subunit genes (nAChRa4 and nAChRb2,
mAChR3, NMDAR1), which while not specific to bfCNs, are
required for the correct function of these neurons within the
basal forebrain (Fig. 6B) (Whiting and Lindstrom, 1988;
Griguoli and Cherubini, 2012).
If the hPSC-derived NSCs were phenotypically similar to
basal forebrain progenitors we would predict that they
would be able to survive and integrate into the basal
forebrain in vivo (Wu et al., 2002). 10 small hES- or
hiPS-derived neurospheres were injected into the medial
septum of 6 adult rats and the grafts were analyzed 8–
9 weeks post surgery. Immunohistochemistry for Human
Nuclear Antigen (HNA) allowed us to distinguish human
cells, revealing three main areas where cells had integrated
into the forebrain; the medial septum (MS), the overlying
white matter of the corpus collosum (CC) and the cortex (CX)
(Fig. 6C). We found that HNA positive cells within the CX
co-expressed the immature neuronal marker Doublecortin
(DCX) (Fig. 6D). HNA+ cells within the MS expressed ChAT,
indicating cholinergic neurons within the grafts (Figs. 6E–K
and Supplementary movie 1). Interestingly DCX was absent
from the MS grafts suggesting the HNA+/ChAT+ neurons were
more mature than those cells found in the cortex.
Importantly there was no evidence of teratoma formation.
This in vivo survival is a major step forward in the
application of hPSCs in the study of AD confirming the
potential for cell replacement therapy. This also augments
the other findings we present herein that phenotypically
accurate human bfCN can be generated from hPSCs, which is
of a standard to use as a model of the adult basal forebrain
cholinergic system.
hPSC-derived NSCs generate neurons that dem-
onstrate mature electrophysiological properties
Calcium imaging was used to assess the gross physiological
activity of neurons within the total population. We stimu-
lated the hPSC-derived bfCNs with both KCl to induce a
membrane potential, and the cholinergic agonist Carbachol
(CCh). We found a robust and widespread response to both,
as shown by the single cell traces in Fig. 7A. These neurons
demonstrated a robust and consistent response, with CCh
inducing a 47.5% ± 7.9 increase and KCl producing a 67.3% ±
8.1 increase in fluorescence above baseline (98 cells were
examined in total from 6 independent coverslips, SEM)
(Fig. 7B). This indicated that the hPSC-derived bfCNs
possessed both functional voltage-gated channels, and
functional cholinergic receptors, which were also able to
induce channel opening. In total 84.7% of KCl respondingneurons were also responsive to CCh, therefore confirming
the primarily cholinergic phenotype within these cultures.
Further confirmation of their functionality came with our
finding that the hPSC-derived bfCNs could release ACh, both
spontaneously, and at an increased rate in response to the
cholinergic agonist CCh (Fig. 7C).
Ultimately a neurons function is its ability to communi-
cate electrically via its synapses. We therefore used
whole-cell patch clamp recording to analyze neuronal action
potential and spontaneous excitatory postsynaptic currents
to assess the electrophysiological properties of the
hPSC-derived bfCNs. The injection of current elicited an
action potential, which was reversibly blocked by the
selective sodium channel blocker, tetrodotoxin TTX (n = 5,
Fig. 7D). We also saw robust spontaneous firing activity,
which was also completely blocked by TTX, but recovered
after removal of TTX (n = 6, Figs. 7E, F). These findings
demonstrate the successful generation of functionally active
neurons, therefore suggesting they are applicable as a
functional in vitro model. Furthermore we carried out an
immunoblot on protein extracted from cultures equivalent
to those used for the electrophysiology and demonstrated
expression of the synaptic marker Synapsin1. This suggests
that the hPSC-derived bfCNs are forming synapses, which is
key to their function (Fig. 7G).Discussion
We have demonstrated the efficient generation of high
numbers of bfCNs from hPSCs via an expandable basal
forebrain NSC intermediate. This is of particular interest as
bfCNs are one of the primary populations affected in AD, and
our protocol provides a robust resource for their in vitro
study (Holtzman et al., 2011; Everitt and Robbins, 1997;
Davies and Maloney, 1976). This work is highly relevant in
light of the recent advent of iPS technology, which has
opened up the possibility of modeling diseases from a
patient's own tissue (Han et al., 2011).
In the embryo the basal forebrain develops from the most
ventral part of the embryonic telencephalon, and this
ventral identity is induced by hedgehog signaling, via the
SHH ligand (Fig. 8) (Ericson et al., 1995a; Shimamura et al.,
1995; Pera and Kessel, 1997; Gunhaga et al., 2000).
Regardless of the original cell line we could reproducibly
and efficiently generate NSCs with a basal forebrain
phenotype using EB-based, non-adherent differentiation or
NAdD (Fig. 8). Specifically we have shown that NAdD
generates higher levels of secreted SHH compared to
differentiation as a monolayer, and this is true regardless
of media composition. Furthermore, hedgehog signaling is
initiated at the stage of early germ layer differentiation in
the EB, the first stage of the NAdD protocol, and prior to the
addition of any exogenous factors or morphogens, which
could influence dorso-ventral cell fate. Timing of this
ventral patterning is in agreement with events in the
developing embryo where the hedgehog signaling is induced
relatively early in development as the germ layers develop
adjacent to the ventral neural tube (Fig. 8) (Briscoe and
Ericson, 1999). Therefore we conclude that it is the unique
3D environment of the EB, which is sufficient to recapitulate
these developmental events in vitro.
Figure 7 hPSC-derived neurons demonstrated physiological and electrical properties typical of mature, functional neurons. (A) Calcium
imaging demonstrated that the application of both the cholinergic agonist CCh and KCl evoked a robust response in the hPSC-derived
neurons, indicative of the opening of specific functional membrane channels resulting in an influx of fluorescent calcium dye. This was
observed as in increase in fluorescence in individual neurons. (B) Quantification demonstrated the application of CCh lead to an average
47.5% ±7.9 increase in fluorescence levels and KCl resulted in a 67.3% ±8.1 increase above baseline (98 cells total, n = 6, SEM)].
(C) hPSC-derived neurons spontaneously released the neurotransmitter acetylcholine (ACh), which significantly increased in response to
CCh, indicating specific cholinergic neuromodulatory ability and definitive proof of their cholinergic function (n = 4, SEM, two tailed
t-test ** p = b0.01). (D) Whole-cell patch clamp electrophysiology was used to assess electrical firing properties of the hPSC-derived
neurons, as shown in these representative voltage-responses to a 40 pA current injection (n = 5). Repetitive trains of action potentials
were observed, which were completely blocked by the sodium channel blocker, TTX (500 nM). This was fully reversible following washout
with aCSF. (E) Representative traces of spontaneous electrical firing activity. The neurons were voltage-clamped at −60 mV (n = 6). This
was completely blocked by the application of TTX (500 nM). Subsequently, spontaneous activity was restored following washout with
aCSF. (F) Summarized data of themean frequency of spontaneous activity from differentiated neurons with control cells firing at a rate of
5.5 ± 0.3 Hz. TTX blocked all spontaneous activity and an aCSF washout restored this spontaneous activity a similar rate of 4.5 ± 0.4 Hz
(n = 6 in all cases, SEM). (G) Immunoblot demonstrating expression of the synaptic marker Synapsin1 (isoforms 1a and 1b) on 8 week
terminally differentiated NAS2 hiPS-derived cultures.
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differentiation system will produce derivatives with telen-
cephalic identity, and this seems somewhat the ‘default’
neural fate of hPSCs (Watanabe et al., 2005; Gaspard et al.,
2008; Li et al., 2009). However dorso-ventral fate is highly
variable between protocols, and this is likely due to
differentiation conditions generating their own intrinsic
dorso-ventral induction (Bissonnette et al., 2011; Watanabe
et al., 2005; Gaspard et al., 2008; Li et al., 2009; Danjo et al.,
2011; Wataya et al., 2008). In terms of ventral forebrain, very
high numbers of neural cells expressing markers of the
ventral/basal forebrain, have only previously been achieved
by the addition of specific doses of extrinsic SHH or other
factors thought to influence this fate (Bissonnette et al., 2011;
Watanabe et al., 2005; Gaspard et al., 2008; Li et al., 2009;
Danjo et al., 2011; Nat et al., 2012; Ma et al., 2012).
Interestingly, however several studies support our evidence
for the early induction of hedgehog signaling in the EB,
however this has never been utilized for bfCN differentiation.It has previously been demonstrated in two studies by Iacovitti
et al., where exogenous ventralizing factors were absent from
an EB-based protocol, which efficiently produced midbrain
neurons with a ventral phenotype (Iacovitti et al., 2007; Cai et
al., 2009). Furthermore, other studies generating non-neural
derivatives also establish that EB formation does generate
high levels of hedgehog signaling (Mfopou et al., 2007; Maye et
al., 2000; Wu et al., 2010). Therefore, although the utilization
of endogenous signaling pathways is not often reported for use
in hPSC differentiation, it is clear that hPSCs have the ability
to generate their own signals, and this does occur in the
absence of over-riding high concentration signaling factors
that are present in many protocols.
Expression of NKX2.1 and LHX8 in the NAdD generated
NSCs was followed by expression of the bfCN transcription
factor ISL1 upon terminal differentiation. Taken together
this indicates that we were able to recapitulate embryonic
events. Recently, two groups published findings indicating the
generation of bfCNs from hES cells (Nilbratt et al., 2010;
Figure 8 Schematic of the generation of ventral NKX2.1+ NSCs, and bfCNs via NAdD of hPSCs in relation to events of the developing
embryonic brain. EB formation with hPSCs generates intrinsic signaling which induces germ layer differentiation (upper panel). The
3D environment supports the secretion of SHH from the EB, resulting in ventralization of the neuroectoderm and generation of NSCs
expressing the ventral telencephalic marker NKX2.1. This parallels events in the embryonic neural tube (lower panel) where SHH is
initially secreted from mesendodermal tissue adjacent to the ventral neural tube, from which the ventral telencephalon develops.
This induces the expression of SHH from the ventral neural tube itself, resulting in a dorso-ventral SHH gradient, with highest SHH
levels required for ventral fate and this similarly results in rapid upregulation of NKX2.1. In the NAdD protocol, the enrichment stage
followed by expansion in the presence of mitogens results in non-adherent neurospheres, made up of an almost pure population of
expanding NKX2.1+ NSCs. They are therefore equivalent to the progenitors in the ventricular zone of the embryonic MGE within the
basal forebrain. Similarly upon terminal differentiation the NSCs efficiently generate bfCNs.
1219NadD of human pluripotent stem cells generates basal forebrain cholinergic neuronsBissonnette et al., 2011). In both cases bfCN differentiation
was dependent on exposing hES cells to known factors
required in the developing basal forebrain either by ectopic
application in the differentiation media or by over-expression
(Nilbratt et al., 2010; Bissonnette et al., 2011). An accurate
developmental model of any neuronal population affected by
neurodegeneration is key to therapeutic progress, as in terms
of neuroprotection, regeneration or replacement, it is crucial
that we understand the factors required for cell differentia-
tion and survival (Nat and Dechant, 2011; Liu, 2011). We
therefore conclude that our NAdD protocol, in the absence of
exogenous factors, better recapitulates developmental events
in the basal forebrain, and thus serves as an accurate model
for studying the development of bfCNs.
In this study hPSC-derived bfCNs were generated via an
expandable NSC intermediate, which maintained the desired
basal forebrain progenitor phenotype, and neurogenic capacity
even after long-term expansion in culture. This scalability is a
required feature of any cell type to be used in regenerative
medicine. Whether it is for application in cell replacement or
for the development of novel drug therapies, both require high
numbers of cells. This, taken together with the absence of
extrinsic factors in our protocol reduces the cost of generating
high numbers of bfCNs, which is crucial for any large-scale
applications, such as drug screening.
Further examination of the hPSC-derived bfCN phenotype
revealed a number of characteristics crucial for a model of
bfCNs in AD. They expressed p75NTR, which is involved in the
development and survival of bfCNs, and significantly has also
been linked to AD pathology (Allen and Dawbarn, 2006).
Furthermore we were able to show long-term survival and
in vivo differentiation of hPSC-derived bfCNs, suggestingthey were able to integrate into the adult basal forebrain.
However, to what extent remains unclear and further work
is required to determine if the hPSC-derived cells were able
to form functional synapses with in vivo neurons.
In addition the hPSC-derived bfCNs had a mature
electrophysiological profile, demonstrating an action poten-
tial through depolarization and also spontaneous electrical
activity. In context of their use as a model of the basal
forebrain cholinergic system, it is well established that AD
pathology has a complex effect on the cholinergic neuro-
modulatory role of bfCNs and their electrical function,
resulting in both hypo- and hyperactivity at synapses (Huang
and Mucke, 2012). This is of major interest to the AD
research field as it is accepted that synaptic dysfunction is
the major cause of cognitive decline, and therefore crucial if
they are to be used as a model of AD pathology, much of
which is only applicable to mature neurons.
In conclusion, we have demonstrated a novel protocol for
the efficient generation of bfCNs from hPSCs, via an
expandable NSC intermediate, which recapitulates basal
forebrain development. This replication of in vivo human
bfCN differentiation provides a valuable in vitro model for
the development of this population, which is otherwise
inaccessible. The mature derivatives of this protocol are an
accurate recapitulation of adult bfCNs, and therefore an
excellent model for the study of the human basal forebrain
cholinergic system, for the development of novel thera-
peutics targeted towards AD (Liu, 2011). Finally, this is
the first incidence of cholinergic differentiation from
hiPSCs and therefore the first method to provide the
opportunity to examine the specific effects of AD on
patient derived bfCNs.
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